Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
5(33%)
Results Posted
25%(1 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
5
33%
Ph phase_1
2
13%
Ph phase_2
2
13%
Ph phase_4
4
27%
Ph phase_3
2
13%

Phase Distribution

2

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
2(13.3%)
Phase 2Efficacy & side effects
2(13.3%)
Phase 3Large-scale testing
2(13.3%)
Phase 4Post-market surveillance
4(26.7%)
N/ANon-phased studies
5(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

5

trials recruiting

Total Trials

15

all time

Status Distribution
Active(8)
Completed(4)
Terminated(2)
Other(1)

Detailed Status

Recruiting4
Completed4
Not yet recruiting3
Terminated1
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
5
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (13.3%)
Phase 22 (13.3%)
Phase 32 (13.3%)
Phase 44 (26.7%)
N/A5 (33.3%)

Trials by Status

not_yet_recruiting320%
recruiting427%
terminated17%
active_not_recruiting17%
completed427%
unknown17%
withdrawn17%

Recent Activity

5 active trials
Showing 5 of 15
active_not_recruitingnot_applicable

Kidney Sodium Content in Cardiorenal Patients

NCT04170855
recruitingphase_4

Optimized Treatment of Pulmonary Edema or Congestion

NCT05276219
recruitingphase_4

A Protocol Based-Furosemide Stress Test to Evaluate Renal Recovery During Continuous Renal Replacement Therapy

NCT06229990
completednot_applicable

Comparison of Plasma Neutrophil Gelatinase-Associated Lipocalin (pNGAL) Level in De-resuscitation With Furosemide Group and Control Group

NCT05939245
recruitingphase_3

18F-DOPA II - PET Imaging Optimization

NCT04706910
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT04170855Not Applicable

Kidney Sodium Content in Cardiorenal Patients

Active Not Recruiting
NCT05276219Phase 4

Optimized Treatment of Pulmonary Edema or Congestion

Recruiting
NCT06229990Phase 4

A Protocol Based-Furosemide Stress Test to Evaluate Renal Recovery During Continuous Renal Replacement Therapy

Recruiting
NCT05939245Not Applicable

Comparison of Plasma Neutrophil Gelatinase-Associated Lipocalin (pNGAL) Level in De-resuscitation With Furosemide Group and Control Group

Completed
NCT04706910Phase 3

18F-DOPA II - PET Imaging Optimization

Recruiting
NCT04216784Phase 4

Compare the Diuretic Effect With Furosemide vs Furosemide and Albumin Combined in Cirrhotic Patients

Terminated
NCT05652322Phase 2

Prolonged Intravenous Therapy Versus Early Initiation of an Oral Loop Diuretic in Decompensated Heart Failure

Withdrawn
NCT05105009Phase 1

Furosemide and Creatinine Tubular Stress Test in Order to Measure Proximal Tubule Residual Function

Completed
NCT06442280Phase 4

SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF

Not Yet Recruiting
NCT06326112Phase 2

Role of Active Deresuscitation After Resuscitation:

Not Yet Recruiting
NCT06273397Not Applicable

Acetazolamide or Metolazone in Acute Heart Failure

Not Yet Recruiting
NCT06024889Phase 1

Acute Effects of Furosemide on Hemodynamics and Pulmonary Congestion in Acute Decompensated Heart Failure.

Completed
NCT03071536Not Applicable

Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation

Recruiting
NCT03750136Not Applicable

Furosemide Alone or Unexpectedly With Solution of Hypertonic Saline in Nephrotic Syndrome

Unknown
NCT03208894Phase 3

Role of Salbutamol and Furosemide in TTN

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15